Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring

Gut

Volumn 60, Issue 12, 2011, Pages 1687-1694

  Sie, Karen K Y ^a   Medline, Alan ^b,c   Van Weel, Jacobine ^d   Sohn, Kyoung Jin ^b   Choi, Sang Woon ^e   Croxford, Ruth ^f   Kim, Young In ^a,b,g,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^d UTRECHT UNIVERSITY   (Netherlands)

^e TUFTS UNIVERSITY   (United States)

^f Statistical Consultant   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RISK; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; EPITHELIUM CELL; FEMALE; FOLIC ACID BLOOD LEVEL; GESTATIONAL AGE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; RISK ASSESSMENT; TUMOR VOLUME; VITAMIN SUPPLEMENTATION; WEANING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; AZOXYMETHANE; CARCINOGENS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; DNA METHYLATION; FEMALE; FOLIC ACID; INTESTINAL MUCOSA; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; WEANING;

EID: 80655124705     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2011.238782     Document Type: Article

References (46)

1. Sanjoaquin MA, Allen N, Couto E, et al. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825-8. (Pubitemid 40101266)
2. Kim DH, Smith-Warner SA, Spiegelman D, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010;21:1919-30.
3. Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134:29-38. (Pubitemid 350309319)
4. Paspatis GA, Karamanolis DG. Folate supplementation and adenomatous colonic polyps. Dis Colon Rectum 1994;37:1340-1.
5. Wu K, Platz EA, Willett WC, et al. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 2009;90:1623-31.
6. Jaszewski R, Misra S, Tobi M, et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol 2008;14:4492-8.
7. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9. (Pubitemid 46883748)
8. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 2007;51:267-92.
9. Kim YI. Folic acid supplementation and cancer risk: point. Cancer Epidemiol Biomarkers Prev 2008;17:2220-5.
10. Min mouse. Cancer Res 2000;60:5434-40.
11. Song J, Sohn KJ, Medline A, et al. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res 2000;60:3191-9. (Pubitemid 30407916)
12. Lindzon GM, Medline A, Sohn KJ, et al. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 2009;30:1536-43.
13. Cravo ML, Mason JB, Dayal Y, et al. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 1992;52:5002-6.
14. Kim YI, Salomon RN, Graeme-Cook F, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 1996;39:732-40. (Pubitemid 26426477)
15. Le Leu RK, Young GP, McIntosh GH. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 2000;21:2261-5. (Pubitemid 32049233)
16. Kim YI. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 2005;135:2703-9.
17. Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007;86:718-27. (Pubitemid 47435840)
18. Bailey RL, Dodd KW, Gahche JJ, et al. Total folate and folic acid intake from foods and dietary supplements in the United States. Am J Clin Nutr 2003-2006;91:231-7.
19. Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003-26.
20. Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
21. Reddy BS. Colon carcinogenesis models for chemoprevention studies. Hematol Oncol Clin North Am 1998;12:963-73. (Pubitemid 28476035)
22. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000;112-113:395-402. (Pubitemid 30138150)
23. National Research Council. Nutrient requirements of the laboratory rat. In: Nutrient Requirements of Laboratory Animals. 4th edn. Wasington, DC: National Academy Press, 1995:11-79.
24. Institute of Medicine. Folate. In: Dietary Reference Intakes for Thiamin, Roboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998:196-305.
25. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002;99:5606-11. (Pubitemid 34411596)
26. Morgan HD, Santos F, Green K, et al. Epigenetic reprogramming in mammals. Hum Mol Genet 2005;14:R47-58. (Pubitemid 40542620)
27. Waterland RA, Dolinoy DC, Lin JR, et al. Maternal methyl supplements increase offspring DNA methylation at Axin Fused. Genesis 2006;44:401-6. (Pubitemid 44454044)
28. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300. (Pubitemid 36950884)
29. Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 2009;106:15424-9.
30. Kamen BA, Nylen PA, Whitehead VM, et al. Lack of dihydrofolate reductase in human tumour and leukemia cells in vivo. Cancer Drug Deliv 1985;2:133-8. (Pubitemid 16157525)
31. Sowers R, Toguchida J, Qin J, et al. mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma. Mol Cancer Ther 2003;2:535-41.
32. Nijhout HF, Reed MC, Budu P, et al. A mathematical model of the folate cycle: new insights into folate homeostasis. J Biol Chem 2004;279:55008-16. (Pubitemid 40066492)
33. Einspahr JG, Alberts DS, Gapstur SM, et al. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev 1997;6:37-48. (Pubitemid 27030426)
34. Akoglu B, Faust D, Milovic V, et al. Folate and chemoprevention of colorectal cancer: is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells? Nutrition 2001;17:652-3. (Pubitemid 32633801)
35. Jaszewski R, Khan A, Sarkar FH, et al. Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines. Am J Physiol 1999;277:C1142-8. (Pubitemid 30045970)
36. Khosraviani K, Weir HP, Hamilton P, et al. Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 2002;51:195-9. (Pubitemid 34791446)
37. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
38. Lawrance AK, Deng L, Rozen R. Methylenetetrahydrofolate reductase deficiency and low dietary folate reduce tumorigenesis in Apc min/+ mice. Gut 2009;58:805-11.
39. Ly A, Lee H, Chen J, et al. Effect of maternal and postweaning folic acid supplementation on mammary tumour risk in the offspring. Cancer Res 2011;71:988-97.
40. Bunin GR, Gallagher PR, Rorke-Adams LB, et al. Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children's oncology group study. Cancer Epidemiol Biomarkers Prev 2006;15:1660-7. (Pubitemid 44497102)
41. Bunin GR, Kuijten RR, Buckley JD, et al. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med 1993;329:536-41. (Pubitemid 23232622)
42. Schuz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 2007;166:433-41. (Pubitemid 46450497)
43. Thompson JR, Gerald PF, Willoughby ML, et al. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a caseecontrol study. Lancet 2001;358:1935-40. (Pubitemid 34072874)
44. Dockerty JD, Herbison P, Skegg DC, et al. Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case - control study. BMC Public Health 2007;7:136.
45. Milne E, Royle JA, Miller M, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer 2010;126:2690-9.
46. Goh YI, Bollano E, Einarson TR, et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther 2007;81:685-91. (Pubitemid 46625103)